Osteoclasts in bone regeneration under type 2 diabetes mellitus

Area of Science:

• Biomedical Engineering
• Endocrinology
• Orthopedics

Background:

• Diabetes mellitus (DM) is a global health issue with impaired bone healing as a significant complication.
• Understanding DM's effect on osteoclasts is crucial for developing treatments for diabetic bone regeneration.
• Existing research on DM's impact on osteoclast activity and matrix degradation is limited and controversial.

Purpose of the Study:

• To investigate the influence of type 2 diabetes mellitus (T2DM) on osteoclast activity and function during alveolar bone regeneration.
• To elucidate the mechanisms by which high glucose concentrations affect osteoclastogenesis and matrix degradation.
• To provide insights for designing targeted therapies and biomaterials for bone repair in diabetic patients.

Main Methods:

• Establishment of a type 2 diabetes mellitus (T2DM) alveolar bone defect model in rats.
• In vitro assessment of osteoclast formation, differentiation, and function under high glucose conditions.
• In vivo evaluation of osteoclast activity, matrix degradation, and bone regeneration in the T2DM model.

Main Results:

• High glucose concentrations significantly inhibited osteoclast formation, differentiation, and function.
• Osteoclast-mediated matrix degradation was markedly reduced in the T2DM model.
• T2DM suppressed osteoclastogenesis and delayed matrix degradation during alveolar bone regeneration in vivo.

Conclusions:

• T2DM negatively impacts osteoclast activity and function, leading to impaired bone regeneration.
• The study clarifies the controversial role of DM in osteoclast behavior and matrix degradation.
• Findings offer valuable insights for developing novel scaffolding materials targeting osteoclasts to enhance bone healing in T2DM patients.